DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
AMITRIPTYLINOXIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMITRIPTYLINOXIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
TYR2U59WMA
Molecule Type:
Small molecule
Molecular Formula:
C20H23NO
Molecular Weight:
293.41
AlogP:
4.18
PSA:
23.06
HBD:
0.0
HBA:
#RotB:
3.0
Source:
POLYTHIAZIDE; RESERPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
POLYTHIAZIDE; RESERPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LINAGLIPTIN;METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
LINAGLIPTIN;METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALUMINUM SULFATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ALUMINUM SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
34S289N54E
Molecule Type:
Small molecule
Molecular Formula:
H2Al2O13S3
Molecular Weight:
360.17
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FLUCLOXACILLIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FLUCLOXACILLIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
4
Combination
Approved
IMMUNE SYSTEM
ORAL
Unknown
Unknown
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORTHALIDONE; METOPROLOL TARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORTHALIDONE; METOPROLOL TARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BITHIONOL
4
Small molecule
Approved
Unknown
Unknown
Acne Vulgaris; Helminthiasis
Unknown
BITHIONOL
×
Maximum Phase:
4
First Approval:
None
UNII:
AMT77LS62O
Molecule Type:
Small molecule
Molecular Formula:
C12H6Cl4O2S
Molecular Weight:
356.06
AlogP:
5.86
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GEMEPROST
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
GEMEPROST
×
Maximum Phase:
4
First Approval:
None
UNII:
45KZB1FOLS
Molecule Type:
Small molecule
Molecular Formula:
C23H38O5
Molecular Weight:
394.55
AlogP:
3.98
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ACECLOFENAC
4
Small molecule
Approved
Unknown
Unknown
Pulpitis; Arthralgia; Arthritis, Rheumatoid; Myalgia; Osteoarthritis; Rheumatic Diseases; Spondylitis
Cyclooxygenase-2 inhibitor
ACECLOFENAC
×
Maximum Phase:
4
First Approval:
None
UNII:
RPK779R03H
Molecule Type:
Small molecule
Molecular Formula:
C16H13Cl2NO4
Molecular Weight:
354.19
AlogP:
3.91
PSA:
75.63
HBD:
2.0
HBA:
#RotB:
6.0
Source:
COARTEM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
COARTEM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GAXILOSE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
GAXILOSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FERROUS GLYCINE SULFATE
4
Small molecule
Approved
Unknown
Unknown
Anemia
Unknown
FERROUS GLYCINE SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
56PS9HY5XI
Molecule Type:
Small molecule
Molecular Formula:
C4H10FeN2O8S
Molecular Weight:
302.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
HYDROCHLOROTHIAZIDE; PROPRANOLOL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ISONIAZID; RIFAMPIN
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ISONIAZID; RIFAMPIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEQUITAZINE
4
Small molecule
Approved
Unknown
Unknown
Hypersensitivity
Unknown
MEQUITAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
Y463242LY2
Molecule Type:
Small molecule
Molecular Formula:
C20H22N2S
Molecular Weight:
322.48
AlogP:
4.63
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
2.0
Source:
DESOGESTREL; ETHINYL ESTRADIOL
4
Combination
Approved
OTHER; PREGNANCY AND GYNECOLOGY
ORAL; ORAL-21; ORAL-28
Unknown
Unknown
DESOGESTREL; ETHINYL ESTRADIOL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ATROPINE; PRALIDOXIME CHLORIDE
4
Combination
Approved
OTHER
INTRAMUSCULAR
Unknown
Unknown
ATROPINE; PRALIDOXIME CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INSULIN, PROTAMINE ZINC
4
Protein
Approved
Unknown
Unknown
Unknown
Unknown
INSULIN, PROTAMINE ZINC
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CELIPROLOL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Adrenergic receptor alpha-2 antagonist
CELIPROLOL
×
Maximum Phase:
4
First Approval:
None
UNII:
DRB57K47QC
Molecule Type:
Small molecule
Molecular Formula:
C20H33N3O4
Molecular Weight:
379.5
AlogP:
2.89
PSA:
90.9
HBD:
3.0
HBA:
#RotB:
9.0
Source:
BENZOIC ACID
4
Small molecule
Approved
Unknown
Unknown
Urinary Tract Infections
Unknown
BENZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
8SKN0B0MIM
Molecule Type:
Small molecule
Molecular Formula:
C7H6O2
Molecular Weight:
122.12
AlogP:
1.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CEREBROLYSIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
CEREBROLYSIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALCURONIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Muscarinic acetylcholine receptor M2 positive allosteric modulator
ALCURONIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
S8U3J5W06N
Molecule Type:
Small molecule
Molecular Formula:
C44H50N4O2+2
Molecular Weight:
666.91
AlogP:
5.48
PSA:
46.94
HBD:
2.0
HBA:
#RotB:
6.0
Source:
SITOSTEROLS
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
SITOSTEROLS
×
Maximum Phase:
4
First Approval:
None
UNII:
G7V636VTDY
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TWINRIX
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TWINRIX
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
ACETIC ACID, GLACIAL; HYDROCORTISONE; NEOMYCIN SULFATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POLICOSANOL
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
POLICOSANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALBUMIN IODINATED I-125 SERUM
4
Protein
Approved
OTHER
INJECTION
Unknown
Unknown
ALBUMIN IODINATED I-125 SERUM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TROPISETRON
4
Small molecule
Approved
Unknown
Unknown
Pain; Nausea
Serotonin 3 (5-HT3) receptor antagonist
TROPISETRON
×
Maximum Phase:
4
First Approval:
None
UNII:
6I819NIK1W
Molecule Type:
Small molecule
Molecular Formula:
C17H20N2O2
Molecular Weight:
284.36
AlogP:
2.95
PSA:
45.33
HBD:
1.0
HBA:
#RotB:
2.0
Source:
GUAIFENESIN; HYDROCODONE BITARTRATE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
GUAIFENESIN; HYDROCODONE BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AM
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
AM
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
280
281
282
283
284
285
286
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA